Quantbot Technologies LP Unity Biotechnology, Inc. Transaction History

Quantbot Technologies LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$1.3 - $3.17 $1,950 - $4,755	-1,500 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$2.91 - $4.5 $4,365 - $6,750	1,500 New	1,500 $4,000
Q4 2020 Feb 12, 2021	SELL	$3.42 - $6.36 $2,052 - $3,816	-600 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$2.94 - $12.43 $1,764 - $7,458	600 New	600 $2,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $14M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.